Peter Attia· MD
I think both of those are unnecessarily high and we typically like to see patients below 20 on both of those
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I think both of those are unnecessarily high and we typically like to see patients below 20 on both of those
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so alt and ast as of now on the lab that I use the upper limit of a LT is 44 maybe 42 and ast is about 40 I think both of those are unnecessarily high and we typically like to see patients below 20 on both of those